Rocket Pharmaceuticals, Inc. (RCKT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 149.83M | 192.73M | 227.68M | 277.15M | 324.49M | 378.18M | 241.75M | 292.73M | 345.16M | 378.22M | 446.87M | 312.07M |
| Cash & Short-Term Investments | 144.38M | 188.93M | 222.76M | 271.49M | 318.16M | 372.34M | 235.66M | 278.82M | 330.31M | 373.18M | 437.17M | 307.04M |
| Cash Only | 49.61M | 77.56M | 75.95M | 32.82M | 49.81M | 163.63M | 65.6M | 38.61M | 35.28M | 55.9M | 225.66M | 45.08M |
| Short-Term Investments | 94.77M | 111.37M | 146.81M | 238.68M | 268.35M | 208.7M | 170.06M | 240.22M | 295.04M | 317.27M | 211.51M | 261.96M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.1M | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.45M | 3.81M | 4.92M | 5.66M | 6.33M | 5.85M | 6.09M | 5.8M | 14.85M | 5.05M | 9.69M | 5.03M |
| Total Non-Current Assets | 135.58M | 137.72M | 140.35M | 143.82M | 146.57M | 149.52M | 151.93M | 153.69M | 154.28M | 188.12M | 151.9M | 149.71M |
| Property, Plant & Equipment | 69.45M | 71.59M | 74.17M | 77.64M | 80.39M | 83.32M | 85.77M | 87.54M | 88.08M | 87.59M | 85.68M | 82.92M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M |
| Intangible Assets | 25.15M | 25.15M | 25.15M | 25.15M | 25.15M | 25.15M | 25.15M | 25.15M | 25.15M | 25.15M | 25.15M | 25.72M |
| Long-Term Investments | 1.34M | 1.34M | 1.36M | 0 | 0 | 0 | 1.36M | 1.36M | 0 | 34.32M | 0 | 0 |
| Other Non-Current Assets | 482K | 482K | 515K | 1.88M | 1.88M | 1.89M | 503K | 481K | 1.9M | 1.91M | 1.91M | 1.9M |
| Total Assets | 285.41M | 330.45M | 368.03M | 420.98M | 471.07M | 527.7M | 393.69M | 446.41M | 499.44M | 566.34M | 598.76M | 461.78M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -39.41% | -37.38% | -6.52% | -5.7% | -5.68% | -6.82% | -34.25% | -3.33% | -2.98% | 2.63% | 43.5% | 6.93% |
| Total Current Liabilities | 24.47M | 30.21M | 31.17M | 43.4M | 35.31M | 40.68M | 39.98M | 37.59M | 32.96M | 48.51M | 33.48M | 34.35M |
| Accounts Payable | 0 | 0 | 0 | 1.71M | 2.94M | 1.63M | 2.77M | 3.06M | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | 119.09 | - | - | - | - |
| Short-Term Debt | 2.92M | 2.92M | 2.91M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 21.54M | 27.29M | 16.83M | 6.34M | 4.13M | 10.32M | 34.36M | 24.38M | 4.19M | 9.93M | 8.36M | 6.01M |
| Current Ratio | 6.12x | 6.38x | 7.30x | 6.39x | 9.19x | 9.30x | 6.05x | 7.79x | 10.47x | 7.80x | 13.35x | 9.09x |
| Quick Ratio | 6.12x | 6.38x | 7.30x | 6.39x | 9.19x | 9.30x | 6.05x | 7.79x | 10.47x | 7.80x | 13.35x | 9.09x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 22.9M | 23.02M | 23.19M | 23.37M | 23.62M | 23.78M | 23.94M | 24.18M | 24.98M | 25.26M | 24.2M | 24.46M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 21.84M | 21.96M | 22.13M | 22.31M | 22.48M | 22.64M | 22.8M | 22.94M | 23.08M | 22.33M | 22.33M | 22.39M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.06M | 1.06M | 1.06M | 1.06M | 1.14M | 1.14M | 1.14M | 1.25M | 1.91M | 2.94M | 1.87M | 2.07M |
| Total Liabilities | 47.37M | 53.23M | 54.36M | 66.77M | 58.93M | 64.47M | 63.92M | 61.78M | 57.94M | 73.77M | 57.68M | 58.81M |
| Total Debt | 24.76M | 24.88M | 25.05M | 25.2M | 25.35M | 25.5M | 25.64M | 25.8M | 25.95M | 25.04M | 25.18M | 25.39M |
| Net Debt | -24.85M | -52.68M | -50.9M | -7.62M | -24.46M | -138.14M | -39.96M | -12.81M | -9.33M | -30.86M | -200.47M | -19.69M |
| Debt / Equity | 0.10x | 0.09x | 0.08x | 0.07x | 0.06x | 0.06x | 0.08x | 0.07x | 0.06x | 0.05x | 0.05x | 0.06x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -102.56x | -11.86x | -105.41x | -144.71x | -128.94x | -126.54x | -140.65x | -146.87x | -130.75x | -125.94x | -130.98x | -139.39x |
| Total Equity | 238.04M | 277.22M | 313.67M | 354.21M | 412.14M | 463.23M | 329.77M | 384.63M | 441.5M | 492.57M | 541.09M | 402.97M |
| Equity Growth % | -42.24% | -40.16% | -4.88% | -7.91% | -6.65% | -5.96% | -39.05% | -4.55% | -3.79% | 0.59% | 47.31% | 3.94% |
| Book Value per Share | 2.12 | 2.49 | 2.81 | 3.19 | 3.74 | 4.75 | 3.50 | 4.10 | 4.72 | 5.28 | 6.55 | 5.01 |
| Total Shareholders' Equity | 238.04M | 277.22M | 313.67M | 354.21M | 412.14M | 463.23M | 329.77M | 384.63M | 441.5M | 492.57M | 541.09M | 402.97M |
| Common Stock | 1.09M | 1.08M | 1.08M | 1.08M | 1.07M | 1.06M | 911K | 910K | 906K | 903K | 901K | 805K |
| Retained Earnings | -1.49B | -1.44B | -1.4B | -1.35B | -1.28B | -1.22B | -1.16B | -1.09B | -1.02B | -959.37M | -899.71M | -837.81M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -47K |
| Accumulated OCI | -112K | -31K | -9K | -107K | -27K | 66K | 213K | -218K | -135K | 319K | -508K | -722K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |